WO2016193997A3 - Process for the preparation of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and pharmaceutically acceptable salts thereof - Google Patents
Process for the preparation of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and pharmaceutically acceptable salts thereof Download PDFInfo
- Publication number
- WO2016193997A3 WO2016193997A3 PCT/IN2016/000142 IN2016000142W WO2016193997A3 WO 2016193997 A3 WO2016193997 A3 WO 2016193997A3 IN 2016000142 W IN2016000142 W IN 2016000142W WO 2016193997 A3 WO2016193997 A3 WO 2016193997A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methylbutan
- dihydroquinoline
- fluorobenzyl
- oxo
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/32—Esters
- C07D215/34—Carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a process for the preparation of 6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid represented by the following structural formula-1 and pharmaceutically acceptable salts thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2784CH2015 | 2015-06-03 | ||
IN2784/CHE/2015 | 2015-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016193997A2 WO2016193997A2 (en) | 2016-12-08 |
WO2016193997A3 true WO2016193997A3 (en) | 2017-01-19 |
Family
ID=57441012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2016/000142 WO2016193997A2 (en) | 2015-06-03 | 2016-06-03 | Process for the preparation of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and pharmaceutically acceptable salts thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016193997A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114213450A (en) * | 2021-12-29 | 2022-03-22 | 南京杰运医药科技有限公司 | Synthesis method of methoxymethyl dimethoxysilane |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004046115A1 (en) * | 2002-11-20 | 2004-06-03 | Japan Tobacco Inc. | 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
WO2011004389A2 (en) * | 2009-06-18 | 2011-01-13 | Matrix Laboratories Ltd | An improved process for the preparation of elvitegravir |
WO2014056464A1 (en) * | 2012-10-12 | 2014-04-17 | Zentiva, K.S. | A new production method and new intermediates of synthesis of elvitegravir |
-
2016
- 2016-06-03 WO PCT/IN2016/000142 patent/WO2016193997A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004046115A1 (en) * | 2002-11-20 | 2004-06-03 | Japan Tobacco Inc. | 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
WO2011004389A2 (en) * | 2009-06-18 | 2011-01-13 | Matrix Laboratories Ltd | An improved process for the preparation of elvitegravir |
WO2014056464A1 (en) * | 2012-10-12 | 2014-04-17 | Zentiva, K.S. | A new production method and new intermediates of synthesis of elvitegravir |
Also Published As
Publication number | Publication date |
---|---|
WO2016193997A2 (en) | 2016-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015110897A3 (en) | Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof | |
WO2016079751A3 (en) | A process for preparation of vortioxetine and polymorphs thereof | |
MX2018001491A (en) | Methods for preparation of bile acids and derivatives thereof. | |
CA2826751C (en) | Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds | |
WO2016159577A3 (en) | 1,2-naphthoquinone derivative and method for preparing same | |
WO2016125191A3 (en) | Processes for the preparation of vortioxetine hydrobromide | |
WO2014192030A3 (en) | An improved process for preparation of dabigatran etexilate and pharmaceutically acceptable acid addition salts thereof | |
WO2016166720A3 (en) | Polymorphs of afatinib and its salts and process for the preparation of quinazolinyl derivatives | |
WO2015068175A3 (en) | An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof | |
WO2016077832A3 (en) | PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS | |
WO2015128875A3 (en) | A process for preparation of dabigatran etexilate mesylate and intermediates thereof | |
WO2015121877A3 (en) | Polymorphs of lomitapide and its salts | |
WO2016142819A3 (en) | Novel process for the preparation of ranolazine | |
WO2014207567A3 (en) | Process for the preparation of abiraterone and intermediates thereof | |
EP3452439A4 (en) | Process for preparation of 3,6-dichloro-2-methoxybenzoic acid (dicamba) | |
WO2015181802A3 (en) | Oral pharmaceutical composition of isotretinoin | |
WO2017098533A3 (en) | Process for preparation of lisdexamphetamine | |
WO2015052568A3 (en) | Solid forms of curcumin and derivatives thereof | |
WO2017093866A3 (en) | An improved process for the preparation of indigo carmine | |
WO2016193997A3 (en) | Process for the preparation of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and pharmaceutically acceptable salts thereof | |
WO2017055932A3 (en) | Improved propionibacterium strains for the production of propionic acid | |
WO2016075703A3 (en) | An improved process for preparation of 5-amino-2,4-di-tert- butylphenol or an acid addition salt thereof | |
WO2015087343A3 (en) | An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof | |
EP3118207A4 (en) | Inclusion compound of 3',5'-cyclicdiadenylic acid, and method for producing same | |
WO2017046816A3 (en) | Process for the preparation of derivatives of benzodioxole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16802705 Country of ref document: EP Kind code of ref document: A2 |